Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
Aug 9 (Reuters) - A U.S. judge on Friday said two patents relating to Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a...
Aug 9 (Reuters) - A U.S. judge on Friday said two patents relating to Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a...